Drug Target Review’s top content picks from 2022
In this article, Drug Target Review’s Izzy Wood and Ria Kakkad share some of the most ground-breaking moments from drug discovery this year.
List view / Grid view
In this article, Drug Target Review’s Izzy Wood and Ria Kakkad share some of the most ground-breaking moments from drug discovery this year.
The study highlights that a monoclonal antibody that targets heroin is effective in blocking the psychoactive and lethal effects of drug abuse in mice.
Drug-initiated activity metabolomics screening discovers the metabolite myristoylglycine, that converts white fat cells to brown fat cells.
Researchers in the US have developed a potential HIV vaccine approach that aims to prompt the creation of broadly neutralising antibodies via mRNA.
Researchers have found that the innate immune system requires two steps to defend against HIV-1, even when the virus is present in small amounts.
A study has shown how Parkinson’s disease may be driven by cell stress-related biochemical events that disrupt a key cellular clean-up system.
Researchers have found a small subset of antibodies that target a site at the base of the influenza virus hemagglutinin protein.
Researchers have designed a new nanoparticle-based vaccine against Ebola that has shown promise in mice and rabbits.
Having synthesised the curcusone D compound, researchers demonstrated its promise as the first BRAT1 inhibitor, making it a potential cancer therapy.
A novel machine learning method can explain how glycans stabilise proteins, aiding the discovery and design of protein-based drugs.
A new vaccine is effective at preventing opioid overdose from fentanyl and carfentanil in rodents, according to a new study.
By combining natural killer cells with a new molecule called Sialyl-Lewis X, researchers were able to treat lymphoma in mice.
Scientists have created a drug discovery platform that enables the discovery and optimisation of RNA-targeting compounds.
This article lists three of the most recent advances in pre-clinical HIV research and vaccine development.
Using cryo-electron microscopy and site-specific mass spectrometry, researchers have mapped the glycans that shield HIV from the immune system.